Chronic blockade of nitric oxide synthesis reduces adiposity and improves insulin resistance in high fat-induced obese mice - PubMed
. 2007 Oct;148(10):4548-56.
doi: 10.1210/en.2006-1371. Epub 2007 Jun 21.
Affiliations
- PMID: 17584959
- DOI: 10.1210/en.2006-1371
Chronic blockade of nitric oxide synthesis reduces adiposity and improves insulin resistance in high fat-induced obese mice
Kyoichiro Tsuchiya et al. Endocrinology. 2007 Oct.
Abstract
Genetic deletion of inducible nitric oxide synthase (NOS) in mice has been shown to improve high-fat diet (HFD)-induced insulin resistance. However, a pathophysiological role of endogenous nitric oxide (NO) in obesity-related insulin resistance remains controversial. To address this issue, we examined the metabolic phenotypes in HFD-induced obese mice with chronic blockade of NO synthesis by a NOS inhibitor, N(G)-nitro-l-arginine methyl ester (L-NAME). Six-week-old male C57BL/6j mice were provided free access to either a standard diet (SD) or a HFD and tap water with or without L-NAME (100 mg/kg.d) for 12 wk. L-NAME treatment significantly attenuated body weight gain of mice fed either SD or HFD without affecting calorie intake. L-NAME treatment in HFD-fed mice improved glucose tolerance and insulin sensitivity. HFD feeding induced inducible NOS mRNA expression, but not the other two NOS isoforms, in white adipose tissue (WAT) and skeletal muscle. L-NAME treatment up-regulated uncoupling protein-1 in brown adipose tissue of HFD-fed mice but down-regulated monocyte chemoattractant protein-1 and CD68 mRNAs levels in WAT. HFD feeding up-regulated leptin mRNA levels but conversely down-regulated adiponectin mRNA levels in WAT, but these effects were unaffected by L-NAME treatment. Moreover, L-NAME treatment also increased peroxisome proliferator-uncoupling protein-3 mRNA levels in skeletal muscles of HFD-fed mice. Increased urinary excretion of norepinephrine after HFD feeding was augmented in L-NAME-treated mice. Insulin-stimulated tyrosine phosphorylation of insulin receptor substrate-1 and serine phosphorylation of Akt/Akt2 in soleus muscle was markedly impaired in HFD-fed mice but reversed by L-NAME treatment. In conclusion, chronic NOS blockade by L-NAME in mice ameliorates HFD-induced adiposity and glucose intolerance, accompanied by reduced adipose inflammation and improved insulin signaling in skeletal muscle, suggesting that endogenous NO plays a modulatory role in the development of obesity-related insulin resistance.
Comment in
-
NO to obesity: does nitric oxide regulate fat oxidation and insulin sensitivity?
Joost HG, Tschöp MH. Joost HG, et al. Endocrinology. 2007 Oct;148(10):4545-7. doi: 10.1210/en.2007-0866. Endocrinology. 2007. PMID: 17876034 Review. No abstract available.
Similar articles
-
Nobiletin improves obesity and insulin resistance in high-fat diet-induced obese mice.
Lee YS, Cha BY, Choi SS, Choi BK, Yonezawa T, Teruya T, Nagai K, Woo JT. Lee YS, et al. J Nutr Biochem. 2013 Jan;24(1):156-62. doi: 10.1016/j.jnutbio.2012.03.014. Epub 2012 Aug 13. J Nutr Biochem. 2013. PMID: 22898571
-
Nitric oxide mediates the insulin sensitizing effects of β-sitosterol in high fat diet-fed rats.
Radika MK, Viswanathan P, Anuradha CV. Radika MK, et al. Nitric Oxide. 2013 Aug 1;32:43-53. doi: 10.1016/j.niox.2013.04.007. Epub 2013 Apr 23. Nitric Oxide. 2013. PMID: 23624268
-
Kang JH, Goto T, Han IS, Kawada T, Kim YM, Yu R. Kang JH, et al. Obesity (Silver Spring). 2010 Apr;18(4):780-7. doi: 10.1038/oby.2009.301. Epub 2009 Oct 1. Obesity (Silver Spring). 2010. PMID: 19798065
-
Regulation of brown adipose tissue development and white fat reduction by L-arginine.
Wu Z, Satterfield MC, Bazer FW, Wu G. Wu Z, et al. Curr Opin Clin Nutr Metab Care. 2012 Nov;15(6):529-38. doi: 10.1097/MCO.0b013e3283595cff. Curr Opin Clin Nutr Metab Care. 2012. PMID: 23075933 Review.
-
L-NAME in the cardiovascular system - nitric oxide synthase activator?
Kopincová J, Púzserová A, Bernátová I. Kopincová J, et al. Pharmacol Rep. 2012;64(3):511-20. doi: 10.1016/s1734-1140(12)70846-0. Pharmacol Rep. 2012. PMID: 22814004 Review.
Cited by
-
Alizadeh M, Daneghian S, Ghaffari A, Ostadrahimi A, Safaeiyan A, Estakhri R, Gargari BP. Alizadeh M, et al. J Res Med Sci. 2010 Nov;15(6):331-43. J Res Med Sci. 2010. PMID: 21526106 Free PMC article.
-
Boa BC, Souza Md, Leite RD, da Silva SV, Barja-Fidalgo TC, Kraemer-Aguiar LG, Bouskela E. Boa BC, et al. PLoS One. 2014 Jul 18;9(7):e102554. doi: 10.1371/journal.pone.0102554. eCollection 2014. PLoS One. 2014. PMID: 25036223 Free PMC article.
-
Ceddia RP, Collins S. Ceddia RP, et al. Clin Sci (Lond). 2020 Mar 13;134(5):473-512. doi: 10.1042/CS20190579. Clin Sci (Lond). 2020. PMID: 32149342 Free PMC article. Review.
-
Regulation of obesity and insulin resistance by nitric oxide.
Sansbury BE, Hill BG. Sansbury BE, et al. Free Radic Biol Med. 2014 Aug;73:383-99. doi: 10.1016/j.freeradbiomed.2014.05.016. Epub 2014 May 28. Free Radic Biol Med. 2014. PMID: 24878261 Free PMC article. Review.
-
Fuentes L, Roszer T, Ricote M. Fuentes L, et al. Mediators Inflamm. 2010;2010:219583. doi: 10.1155/2010/219583. Epub 2010 May 20. Mediators Inflamm. 2010. PMID: 20508742 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous